1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Oncology Biosimilars Market Size Growth Rate by Type (2020-2025)
1.3.2 mAb
1.3.3 Immunomodulators
1.3.4 Hematopoietic Agents
1.3.5 G-CSF
1.3.6 Others
1.4 Market Segment by Application
1.4.1 Global Oncology Biosimilars Market Share by Application (2020-2025)
1.4.2 Retail Pharmacies
1.4.3 Hospital Pharmacy
1.4.4 Online Pharmacy
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oncology Biosimilars Market Size
2.1.1 Global Oncology Biosimilars Revenue 2015-2025
2.1.2 Global Oncology Biosimilars Sales 2015-2025
2.2 Oncology Biosimilars Growth Rate by Regions
2.2.1 Global Oncology Biosimilars Sales by Regions 2015-2019
2.2.2 Global Oncology Biosimilars Revenue by Regions 2015-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Oncology Biosimilars Sales by Manufacturers
3.1.1 Oncology Biosimilars Sales by Manufacturers 2015-2019
3.1.2 Oncology Biosimilars Sales Market Share by Manufacturers 2015-2019
3.2 Revenue by Manufacturers
3.2.1 Oncology Biosimilars Revenue by Manufacturers (2015-2019)
3.2.2 Oncology Biosimilars Revenue Share by Manufacturers (2015-2019)
3.2.3 Global Oncology Biosimilars Market Concentration Ratio (CR5 and HHI)
3.3 Oncology Biosimilars Price by Manufacturers
3.4 Key Manufacturers Oncology Biosimilars Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Oncology Biosimilars Market
3.6 Key Manufacturers Oncology Biosimilars Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 mAb Sales and Revenue (2015-2019)
4.1.2 Immunomodulators Sales and Revenue (2015-2019)
4.1.3 Hematopoietic Agents Sales and Revenue (2015-2019)
4.1.4 G-CSF Sales and Revenue (2015-2019)
4.1.5 Others Sales and Revenue (2015-2019)
4.2 Global Oncology Biosimilars Sales Market Share by Type
4.3 Global Oncology Biosimilars Revenue Market Share by Type
4.4 Oncology Biosimilars Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Oncology Biosimilars Sales by Application
6 United States
6.1 United States Oncology Biosimilars Breakdown Data by Company
6.2 United States Oncology Biosimilars Breakdown Data by Type
6.3 United States Oncology Biosimilars Breakdown Data by Application
7 European Union
7.1 European Union Oncology Biosimilars Breakdown Data by Company
7.2 European Union Oncology Biosimilars Breakdown Data by Type
7.3 European Union Oncology Biosimilars Breakdown Data by Application
8 China
8.1 China Oncology Biosimilars Breakdown Data by Company
8.2 China Oncology Biosimilars Breakdown Data by Type
8.3 China Oncology Biosimilars Breakdown Data by Application
9 Rest of World
9.1 Rest of World Oncology Biosimilars Breakdown Data by Company
9.2 Rest of World Oncology Biosimilars Breakdown Data by Type
9.3 Rest of World Oncology Biosimilars Breakdown Data by Application
9.4 Rest of World Oncology Biosimilars Breakdown Data by Countries
9.4.1 Rest of World Oncology Biosimilars Sales by Countries
9.4.2 Rest of World Oncology Biosimilars Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Celltrion
10.1.1 Celltrion Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Oncology Biosimilars
10.1.4 Oncology Biosimilars Product Introduction
10.1.5 Celltrion Recent Development
10.2 Biocon
10.2.1 Biocon Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Oncology Biosimilars
10.2.4 Oncology Biosimilars Product Introduction
10.2.5 Biocon Recent Development
10.3 Dr. Reddy\'s Laboratories
10.3.1 Dr. Reddy\'s Laboratories Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Oncology Biosimilars
10.3.4 Oncology Biosimilars Product Introduction
10.3.5 Dr. Reddy\'s Laboratories Recent Development
10.4 STADA Arzneimittel AG
10.4.1 STADA Arzneimittel AG Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Oncology Biosimilars
10.4.4 Oncology Biosimilars Product Introduction
10.4.5 STADA Arzneimittel AG Recent Development
10.5 Intas Pharmaceuticals
10.5.1 Intas Pharmaceuticals Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Oncology Biosimilars
10.5.4 Oncology Biosimilars Product Introduction
10.5.5 Intas Pharmaceuticals Recent Development
10.6 Pfizer
10.6.1 Pfizer Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Oncology Biosimilars
10.6.4 Oncology Biosimilars Product Introduction
10.6.5 Pfizer Recent Development
10.7 Sandoz International
10.7.1 Sandoz International Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Oncology Biosimilars
10.7.4 Oncology Biosimilars Product Introduction
10.7.5 Sandoz International Recent Development
10.8 Teva Pharmaceutical Industries Ltd
10.8.1 Teva Pharmaceutical Industries Ltd Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Oncology Biosimilars
10.8.4 Oncology Biosimilars Product Introduction
10.8.5 Teva Pharmaceutical Industries Ltd Recent Development
10.9 Apotex
10.9.1 Apotex Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Oncology Biosimilars
10.9.4 Oncology Biosimilars Product Introduction
10.9.5 Apotex Recent Development
10.10 BIOCAD
10.10.1 BIOCAD Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Oncology Biosimilars
10.10.4 Oncology Biosimilars Product Introduction
10.10.5 BIOCAD Recent Development
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Oncology Biosimilars Sales Channels
11.2.2 Oncology Biosimilars Distributors
11.3 Oncology Biosimilars Customers
12 Market Forecast
12.1 Global Oncology Biosimilars Sales and Revenue Forecast 2020-2025
12.2 Global Oncology Biosimilars Sales Forecast by Type
12.3 Global Oncology Biosimilars Sales Forecast by Application
12.4 Oncology Biosimilars Forecast by Regions
12.4.1 Global Oncology Biosimilars Sales Forecast by Regions 2020-2025
12.4.2 Global Oncology Biosimilars Revenue Forecast by Regions 2020-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
